This inventor holds 48 USPTO granted patents and 1 EPO patent, primarily in Chemokine Receptor Antagonists. Top assignee: Schering Corporation. Active years: 1977-2012.
Location History:
- East Orange, NJ (US) (1977)
- West Orange, NJ (US) (1978 - 1987)
- Caldwell, NJ (US) (1986 - 2012)
Company Filing History:
Years Active: 1977-2012
Areas of Expertise:
Title: The Innovative Work of Inventor Stuart W McCombie
Introduction: Stuart W McCombie is a prominent inventor based in Caldwell, NJ, with an impressive portfolio of 48 patents to his name. His groundbreaking contributions in the field of pharmaceuticals have significantly impacted the medical industry.
Latest Patents: McCombie's latest patents include cutting-edge inventions such as Piperazine derivatives useful as CCR5 antagonists and Cannabinoid receptor ligands. These innovations highlight his focus on developing compounds with anti-inflammatory and immunomodulatory properties, offering new treatment possibilities for cancer, inflammatory, immunomodulatory, and respiratory diseases.
Career Highlights: Stuart W McCombie showcases his expertise as an inventor at Schering Corporation, a renowned pharmaceutical company. His dedication to research and development has led to the creation of numerous patented technologies that have the potential to revolutionize the healthcare landscape.
Collaborations: McCombie has collaborated closely with esteemed coworkers Susan F Vice and Jayaram R Tagat. Together, they have worked on innovative projects that have resulted in cutting-edge pharmaceutical solutions.
Conclusion: Stuart W McCombie's trailblazing work as an inventor exemplifies his commitment to advancing healthcare through innovative technologies. His numerous patents and collaborations stand as a testament to his passion for driving positive change in the medical field.